IL244850B - Stabilized epinaconazole preparations, and their uses - Google Patents
Stabilized epinaconazole preparations, and their usesInfo
- Publication number
- IL244850B IL244850B IL244850A IL24485016A IL244850B IL 244850 B IL244850 B IL 244850B IL 244850 A IL244850 A IL 244850A IL 24485016 A IL24485016 A IL 24485016A IL 244850 B IL244850 B IL 244850B
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- stabilized
- stabilized efinaconazole
- efinaconazole compositions
- efinaconazole
- Prior art date
Links
- NFEZZTICAUWDHU-RDTXWAMCSA-N efinaconazole Chemical compound N1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)CCC(=C)CC1 NFEZZTICAUWDHU-RDTXWAMCSA-N 0.000 title 1
- 229960003937 efinaconazole Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361886569P | 2013-10-03 | 2013-10-03 | |
| US201461922867P | 2014-01-01 | 2014-01-01 | |
| PCT/US2014/058911 WO2015051183A1 (en) | 2013-10-03 | 2014-10-02 | Stabilized efinaconazole compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL244850A0 IL244850A0 (en) | 2016-05-31 |
| IL244850B true IL244850B (en) | 2020-04-30 |
Family
ID=52777446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL244850A IL244850B (en) | 2013-10-03 | 2016-03-31 | Stabilized epinaconazole preparations, and their uses |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9662394B2 (enExample) |
| EP (1) | EP3052487B1 (enExample) |
| JP (3) | JP6516759B2 (enExample) |
| KR (1) | KR102320051B1 (enExample) |
| CN (2) | CN110433291B (enExample) |
| AU (1) | AU2014329421B2 (enExample) |
| CA (1) | CA2924748C (enExample) |
| IL (1) | IL244850B (enExample) |
| MX (1) | MX363386B (enExample) |
| MY (1) | MY179756A (enExample) |
| PH (1) | PH12016500586B1 (enExample) |
| SG (1) | SG11201602596UA (enExample) |
| WO (1) | WO2015051183A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090175810A1 (en) | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
| US8039494B1 (en) | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
| WO2015051183A1 (en) | 2013-10-03 | 2015-04-09 | Dow Pharmaceutical Sciences, Inc. | Stabilized efinaconazole compositions |
| CN112999223A (zh) * | 2013-11-22 | 2021-06-22 | 博世健康爱尔兰有限公司 | 抗感染的方法、组合物和装置 |
| CN106918672B (zh) * | 2015-12-28 | 2021-02-09 | 中美华世通生物医药科技（武汉）有限公司 | 利用hplc测定艾氟康唑原料药及其制剂中有关物质的方法 |
| EP3556368B1 (en) * | 2016-12-16 | 2021-05-26 | Kaneka Corporation | Onychomycosis therapeutic agent |
| WO2019077163A2 (en) * | 2017-10-20 | 2019-04-25 | Galenicum Health S.L. | PHARMACEUTICAL DEVICE |
| JP7430070B2 (ja) * | 2019-02-08 | 2024-02-09 | 沢井製薬株式会社 | エフィナコナゾール含有爪外用液 |
| KR102060546B1 (ko) | 2019-06-07 | 2019-12-30 | 주식회사 바이오빌리프 | 에피나코나졸을 함유하는 용액 형태의 국소 투여용 약학 조성물 |
| KR102352960B1 (ko) * | 2019-06-07 | 2022-01-19 | 주식회사 바이오빌리프 | 에피나코나졸을 함유하는 용액 형태의 국소 투여용 약학 조성물 |
| WO2021054533A2 (ko) * | 2019-09-17 | 2021-03-25 | 주식회사 바이오빌리프 | 산으로서 소르빈산을 포함하는 안정화된 에피나코나졸-함유 약학 조성물 |
| KR20210032665A (ko) * | 2019-09-17 | 2021-03-25 | 주식회사 바이오빌리프 | 킬레이트화제 및 항산화제의 조합을 포함하는 안정화된 에피나코나졸-함유 약학 조성물 |
| WO2021054531A2 (ko) * | 2019-09-17 | 2021-03-25 | 주식회사 바이오빌리프 | 항산화제를 포함하는 안정화된 에피나코나졸-함유 약학 조성물 |
| KR20210032672A (ko) * | 2019-09-17 | 2021-03-25 | 주식회사 바이오빌리프 | 에피나코나졸을 함유하는 안정화된 약학 조성물 |
| KR20210032662A (ko) * | 2019-09-17 | 2021-03-25 | 주식회사 바이오빌리프 | 킬레이트화제를 포함하는 안정화된 에피나코나졸-함유 약학 조성물 |
| WO2021054535A2 (ko) * | 2019-09-17 | 2021-03-25 | 주식회사 바이오빌리프 | 킬레이트화제, 항산화제, 및 산의 조합을 포함하는 안정화된 에피나코나졸-함유 약학 조성물 |
| KR102266145B1 (ko) | 2019-09-26 | 2021-06-17 | 대봉엘에스 주식회사 | 비정질 에피나코나졸 고체 분산체 |
| JP2021054781A (ja) | 2019-09-26 | 2021-04-08 | デボン エルエス，リミテッド | 共結晶形エフィナコナゾール、及びその製造方法 |
| WO2021132348A1 (ja) * | 2019-12-24 | 2021-07-01 | 科研製薬株式会社 | エフィナコナゾールを含有する医薬 |
| KR102394599B1 (ko) * | 2020-03-19 | 2022-05-06 | 동아에스티 주식회사 | 에피나코나졸을 함유하는 국소 투여용 약학 조성물 |
| WO2021245204A1 (en) | 2020-06-03 | 2021-12-09 | The Materia Company Limited | Stable formulation of efinaconazole |
| JP7664026B2 (ja) * | 2020-08-06 | 2025-04-17 | 沢井製薬株式会社 | エフィナコナゾール含有爪外用液 |
| JP2022547755A (ja) * | 2020-08-14 | 2022-11-16 | ビーエルアンドエイチ カンパニー，リミテッド | 白癬を防止又は処置するための医薬組成物 |
| KR102729906B1 (ko) | 2020-10-30 | 2024-11-14 | 주식회사 대웅제약 | 항진균제를 포함하는 안정화된 조성물 |
| KR102301743B1 (ko) | 2020-12-29 | 2021-09-13 | 대봉엘에스 주식회사 | 에피나코나졸 경구용 조성물 |
| WO2022170147A1 (en) * | 2021-02-05 | 2022-08-11 | Acp Laboratories Llc | Topical composition for treating fungi forming on a user's body |
| KR102863832B1 (ko) | 2021-05-04 | 2025-09-25 | 주식회사 제뉴원사이언스 | 에피나코나졸을 함유하는 액상 형태의 약학적 조성물 |
| WO2022235048A1 (ko) * | 2021-05-04 | 2022-11-10 | 주식회사 제뉴원사이언스 | 에피나코나졸을 함유하는 액상 형태의 약학적 조성물 |
| KR20230158920A (ko) | 2022-05-12 | 2023-11-21 | 주식회사한국파마 | 에피나코나졸을 함유하는 안정화된 국소투여용 약학 조성물 |
| KR102842759B1 (ko) | 2022-05-20 | 2025-08-06 | 주식회사한국파마 | 항진균제로서 에피나코나졸을 함유하는 약학 조성물 |
| KR102597564B1 (ko) * | 2023-03-03 | 2023-11-03 | 장병모 | 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (117)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE41306C (de) | A. STORIE VAN DEN ABEELE in Brügge, Belgien | Tabak-Trockner | ||
| US3655290A (en) | 1970-10-02 | 1972-04-11 | Griffith & Associates Inc | Applicator instrument |
| US4052513A (en) | 1974-12-13 | 1977-10-04 | Plough, Inc. | Stable topical anesthetic compositions |
| DE3106635A1 (de) | 1981-02-23 | 1982-09-09 | Bayer Ag | Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften |
| US4384589A (en) | 1981-07-27 | 1983-05-24 | American Cyanamid Company | Novel liquid delivery system for toiletries |
| US4912124A (en) | 1984-02-23 | 1990-03-27 | Ortho Pharmaceutical Corporation | Antifungal dermatological solution |
| JPS6234955A (ja) | 1985-08-01 | 1987-02-14 | ダウ コ−ニング コ−ポレ−ション | 透明シリコ−ン組成物 |
| WO1987002580A1 (en) | 1985-11-04 | 1987-05-07 | Dermatological Products Of Texas | Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same |
| DE3544983A1 (de) | 1985-12-19 | 1987-06-25 | Hoechst Ag | Antimykotisch wirksamer nagellack |
| US5208257A (en) * | 1986-04-21 | 1993-05-04 | Kabara Jon J | Topical antimicrobial pharmaceutical compositions and methods |
| JPS63188609A (ja) | 1987-01-30 | 1988-08-04 | Sansho Seiyaku Kk | 着色を防止した外用剤 |
| DE3720147A1 (de) | 1987-06-16 | 1988-12-29 | Hoechst Ag | Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung |
| CA2008775C (en) | 1989-02-24 | 1998-12-22 | Alberto Ferro | Nail lacquer |
| FR2673537B1 (fr) | 1991-03-08 | 1993-06-11 | Oreal | Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes. |
| US5449715A (en) * | 1991-09-17 | 1995-09-12 | Isp Investments Inc. | Colorless, non-toxic, stabilized aqueous solution of a C1-C5 alkyl vinyl ether and maleic acid copolymers |
| CA2129828A1 (en) | 1992-02-12 | 1993-08-19 | Giovanni Lucchetti | Liposomal itraconazole formulations |
| DE4212105A1 (de) | 1992-04-10 | 1993-10-14 | Roehm Pharma Gmbh | Nagellack zur Behandlung von Onychomykosen |
| GB9308103D0 (en) | 1993-04-20 | 1993-06-02 | Unilever Plc | Cosmetic composition |
| CA2162463C (en) | 1993-05-10 | 2006-01-03 | Takanobu Naito | Azolylamine derivative |
| US5916545A (en) | 1993-07-28 | 1999-06-29 | Pfizer Inc. | Antifungal nail solution |
| US5391367A (en) | 1993-07-28 | 1995-02-21 | Pfizer Inc. | Antifungal nail solution |
| US5461068A (en) | 1993-09-29 | 1995-10-24 | Corwood Laboratories, Inc. | Imidazole derivative tincture and method of manufacture |
| JP3792252B2 (ja) | 1993-09-29 | 2006-07-05 | アルザ・コーポレーション | オキシブチニンのためのモノグリセリド／乳酸エステル透過促進剤 |
| JP3608209B2 (ja) | 1993-10-27 | 2005-01-05 | 大正製薬株式会社 | クロタミトン配合外用剤 |
| FR2711898B1 (fr) | 1993-11-05 | 1995-12-29 | Oreal | Pinceau pour appliquer du vernis à ongles, ou un produit analogue. |
| US6040266A (en) | 1994-02-22 | 2000-03-21 | Ultramet | Foam catalyst support for exhaust purification |
| FR2717057B1 (fr) | 1994-03-14 | 1996-04-12 | Oreal | Pinceau de vernis à ongles et ensemble d'application de vernis à ongles muni d'un tel pinceau. |
| US5487776A (en) | 1994-03-17 | 1996-01-30 | Nimni; Marcel | Anti-fungal nail lacquer and method therefor |
| US6538039B2 (en) | 1994-04-29 | 2003-03-25 | Laboratoire L. Lafon | Pharmaceutical dosage form for transdermal administration |
| AU3633295A (en) | 1994-09-07 | 1996-03-27 | Johnson & Johnson Consumer Products, Inc. | Retinoid compositions |
| US5696164A (en) | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
| WO1996030011A1 (en) | 1995-03-30 | 1996-10-03 | Bioplex, L.C. | Topical antimycotic compositions |
| US5549930A (en) | 1995-05-25 | 1996-08-27 | Reysis; Moisei | Dryer and top coat for nail polish |
| US7094422B2 (en) | 1996-02-19 | 2006-08-22 | Acrux Dds Pty Ltd. | Topical delivery of antifungal agents |
| US5696105A (en) | 1996-03-14 | 1997-12-09 | Hackler; Walter A. | Antifungal nail composition |
| US5874069A (en) | 1997-01-24 | 1999-02-23 | Colgate-Palmolive Company | Cosmetic composition containing silicon-modified amides as thickening agents and method of forming same |
| JP4227677B2 (ja) | 1996-12-10 | 2009-02-18 | 杏林製薬株式会社 | 被膜形成性抗真菌剤組成物 |
| IL132096A0 (en) | 1997-03-31 | 2001-03-19 | Johnson & Johnson Consumer | Solvent system for enhanced penetration of pharmaceutical compounds |
| US6207142B1 (en) | 1997-04-14 | 2001-03-27 | Janssen Pharmaceutica N.V. | Compositions containing an antifungal and a cationic agent |
| US6165484A (en) * | 1997-08-26 | 2000-12-26 | Wake Forest University | EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections |
| US6197305B1 (en) | 1998-01-05 | 2001-03-06 | Farmo-Nat Ltd. | Anti-fungal compositions with prolonged activity |
| KR100269323B1 (ko) | 1998-01-16 | 2000-10-16 | 윤종용 | 반도체장치의백금막식각방법 |
| US20020022660A1 (en) | 1998-01-20 | 2002-02-21 | Hanuman B. Jampani | Deep penetrating antimicrobial compositions |
| US5997893A (en) | 1998-01-20 | 1999-12-07 | Ethicon, Inc. | Alcohol based anti-microbial compositions with cosmetic appearance |
| US6022551A (en) | 1998-01-20 | 2000-02-08 | Ethicon, Inc. | Antimicrobial composition |
| US5972358A (en) | 1998-01-20 | 1999-10-26 | Ethicon, Inc. | Low tack lotion, gels and creams |
| US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| BR9909351A (pt) | 1998-04-03 | 2000-12-12 | Colgate Palmolive Co | Composição cosmética |
| US6306375B1 (en) | 1998-05-01 | 2001-10-23 | The Procter & Gamble Company | Long wear nail polish having defined surface properties |
| US20030007939A1 (en) | 1998-07-31 | 2003-01-09 | Howard Murad | Pharmaceutical compositions and methods for managing dermatological conditions |
| US6264927B1 (en) | 1998-08-27 | 2001-07-24 | Elmer P. Monahan | Topical solution and method for the treatment of nail fungus |
| DE59911740D1 (de) | 1998-09-10 | 2005-04-14 | Bioequal Ag Muttenz | Topisch anwendbare mittel gegen nagelpilzerkrankungen |
| US7026308B1 (en) | 1999-06-25 | 2006-04-11 | The Procter & Gamble Company | Topical anti-microbial compositions |
| DE60042453D1 (de) | 1999-07-28 | 2009-08-06 | Kaken Pharma Co Ltd | Verfahren zum nachweis pathogener mikroorganismen und antimikrobieller mittel, verfahren zum nachweis der arzneimittelwirkung antimikrobieller mittel und antimikrobielle mittel |
| MXPA02001144A (es) | 1999-07-30 | 2002-08-20 | Procter & Gamble | Metodo para tratar y evitar trastornos de dedo. |
| JP4780429B2 (ja) * | 2000-04-07 | 2011-09-28 | 大正製薬株式会社 | ミノキシジル含有製剤 |
| US6433073B1 (en) | 2000-07-27 | 2002-08-13 | 3M Innovative Properties Company | Polyurethane dispersion in alcohol-water system |
| US6676953B2 (en) | 2001-01-26 | 2004-01-13 | Don L. Hexamer | Antifungal composition and method for human nails |
| US6585963B1 (en) | 2001-02-15 | 2003-07-01 | Watson Pharmaceuticals, Inc. | Nail compositions and methods of administering same |
| US20030039621A1 (en) | 2001-04-10 | 2003-02-27 | L'oreal | Two-coat make-up product, its use and a kit containing the make-up product |
| US6664292B2 (en) | 2001-06-04 | 2003-12-16 | Mark H. Bogart | Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor |
| US6821508B2 (en) | 2001-06-27 | 2004-11-23 | Rutgers, The State University | Composition and method for topical nail treatment |
| AU2002331001A1 (en) | 2001-08-07 | 2003-02-24 | Dow Corning Corporation | Hair and skin care compositions containing siloxane-based polyamide copolymers |
| US7043791B2 (en) | 2001-10-16 | 2006-05-16 | Aubex Corporation | Applicator |
| US6846837B2 (en) | 2002-06-21 | 2005-01-25 | Howard I. Maibach | Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| JP2004083439A (ja) | 2002-08-23 | 2004-03-18 | Ss Pharmaceut Co Ltd | 爪用抗真菌外用剤 |
| DE60318867T2 (de) | 2002-09-05 | 2009-01-15 | Galderma S.A. | Lösung für die anwendung an nägeln |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US20050142094A1 (en) | 2003-03-12 | 2005-06-30 | Manoj Kumar | Use of repeat sequence protein polymers in personal care compositions |
| US20040180025A1 (en) | 2003-03-12 | 2004-09-16 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
| AU2004224326B2 (en) | 2003-03-21 | 2010-04-22 | Nexmed Holdings, Inc. | Antifungal nail coat and method of use |
| FR2856301B1 (fr) | 2003-06-23 | 2007-08-03 | Galderma Res & Dev | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile |
| GB2407496A (en) | 2003-10-27 | 2005-05-04 | Dow Corning | Method for forming a polysiloxane film on a biological surface |
| FR2862540B1 (fr) | 2003-11-21 | 2007-03-30 | Galderma Res & Dev | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile |
| MXPA06005587A (es) | 2003-11-21 | 2006-08-11 | Galderma Res & Dev | Composicion rociable para administracion de derivados de vitamina d. |
| WO2005065668A2 (en) | 2003-12-29 | 2005-07-21 | Qlt Usa, Inc. | Topical compositions comprising halo-deoxyadenosines for treatment of skin disorders |
| US7622844B1 (en) | 2003-12-30 | 2009-11-24 | Hipercon, Llc | Metal fiber brush interface conditioning |
| US20050176650A1 (en) | 2004-02-09 | 2005-08-11 | Xanodyne Pharmacal, Inc. | Stable parenteral formulation of levomepromazine and a method for stabilizing said formulation |
| FR2871697B1 (fr) | 2004-06-17 | 2007-06-29 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile |
| US20060008538A1 (en) | 2004-07-07 | 2006-01-12 | Wu Jeffrey M | Methods of treating the skin |
| US20070082039A1 (en) | 2004-10-18 | 2007-04-12 | Jones Gerald S Jr | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids |
| US20060110415A1 (en) | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
| US20060165747A1 (en) | 2005-01-24 | 2006-07-27 | David Rolf | Antifungal composition, method and kit for topically treating onychomycosis |
| EP3424932B1 (en) | 2005-02-16 | 2021-04-07 | Anacor Pharmaceuticals, Inc | Boronophthalides for therapeutic use |
| US20060280706A1 (en) | 2005-05-25 | 2006-12-14 | L'oreal | Rinse-off cosmetic composition containing interference particles |
| US20070071705A1 (en) | 2005-09-29 | 2007-03-29 | De Oliveira Monica A M | Topical anti-microbial compositions |
| EP1959929A4 (en) | 2005-12-14 | 2012-08-15 | Zars Pharma Inc | COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING |
| US20070142478A1 (en) | 2005-12-21 | 2007-06-21 | Erning Xia | Combination antimicrobial composition and method of use |
| KR20080110984A (ko) | 2005-12-30 | 2008-12-22 | 아나코르 파마슈티칼스 인코포레이티드 | 보론함유 소분자 |
| CN101460060A (zh) | 2006-03-01 | 2009-06-17 | 特莱斯特拉塔公司 | 局部治疗焦油响应性皮肤病用的组合物和方法 |
| US20070207107A1 (en) | 2006-03-03 | 2007-09-06 | Gareth Winckle | Silicone based emulsions for topical drug delivery |
| CA2645073A1 (en) | 2006-03-08 | 2007-09-13 | Nuviance, Inc. | Transdermal drug delivery compositions and topical compositions for application on the skin |
| US8268876B2 (en) | 2006-03-08 | 2012-09-18 | Nihon Nohyaku Co., Ltd. | Pharmaceutical composition for external use |
| US7950865B2 (en) | 2006-03-21 | 2011-05-31 | L'oreal | Packaging and applicator device |
| EP2010220B1 (en) | 2006-04-03 | 2022-02-16 | Ceva Animal Health Pty Ltd | Stabilized pentosan polysulfate (pps) formulations |
| WO2008001200A2 (en) | 2006-06-29 | 2008-01-03 | Antares Pharma Ipl Ag | Transdermal composition having enhanced color stability |
| MXPA06008988A (es) | 2006-08-08 | 2008-02-07 | Fernando Ahumada Ayala | Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas). |
| US20080317684A1 (en) | 2006-09-06 | 2008-12-25 | Isw Group, Inc. | Topical Compositions |
| PT2116243E (pt) | 2006-12-28 | 2010-10-26 | Kaken Pharma Co Ltd | Composição de gel para tratamento de micoses |
| WO2008124131A1 (en) | 2007-04-05 | 2008-10-16 | The John Hopkins University | Antifungal agents as neuroprotectants |
| US20090175810A1 (en) * | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
| JP2009263346A (ja) | 2008-03-31 | 2009-11-12 | Kose Corp | カイネチンを含有する乳化型化粧料 |
| AU2009339445A1 (en) * | 2009-02-05 | 2011-08-18 | Targeted Delivery Technologies Limited | Methods of reducing the proliferation and viability of microbial agents |
| JP5654497B2 (ja) | 2009-02-13 | 2015-01-14 | トピカ ファーマシューティカルズ，インコーポレイテッド | 抗真菌製剤 |
| FR2942716B1 (fr) | 2009-03-06 | 2011-04-15 | Galderma Res & Dev | Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle |
| US20120183531A1 (en) | 2009-07-14 | 2012-07-19 | Biogen Idee Ma Inc | Methods for Inhibiting Yellow Color Formation in a Composition |
| WO2011045765A1 (en) * | 2009-10-14 | 2011-04-21 | Scuola Internazionale Superiore Di Studi Avanzati | TEMPORALLY PATTERNED OVEREXPRESSION OF Foxg1 AND Emx2 TRANSCRIPTION FACTOR GENES IN NEURAL PRECURSORS FOR BRAIN TISSUE REPAIR |
| WO2011064558A2 (en) * | 2009-11-30 | 2011-06-03 | Cipla Limited | Pharmaceutical composition |
| FR2954164B1 (fr) | 2009-12-18 | 2012-03-16 | Galderma Pharma Sa | Composition antifongique destinee a etre appliquee sur l'ongle perfore |
| JP2013526565A (ja) * | 2010-05-20 | 2013-06-24 | ヒョン チョン，チュン | 抗菌及び抗真菌効果に優れた皮膚外用剤組成物 |
| RS62583B1 (sr) | 2010-06-29 | 2021-12-31 | Merck Sharp & Dohme | Formulacije intravenskog rastvora sa posakonazolom, stabilisane supstituisanim beta-ciklodekstrinom |
| US8039494B1 (en) | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
| US8871942B2 (en) * | 2010-08-31 | 2014-10-28 | Kaken Pharmaceutical Co., Ltd. | Process for producing 1-triazole-2-butanol derivatives |
| JP6005344B2 (ja) | 2011-07-05 | 2016-10-12 | 科研製薬株式会社 | 爪白癬薬用塗布具 |
| HK1211311A1 (en) | 2012-02-28 | 2016-05-20 | 锡德克斯药物公司 | Alkylated cyclodextrin compositions and processes for preparing and using the same |
| WO2015051183A1 (en) | 2013-10-03 | 2015-04-09 | Dow Pharmaceutical Sciences, Inc. | Stabilized efinaconazole compositions |
| CN112999223A (zh) | 2013-11-22 | 2021-06-22 | 博世健康爱尔兰有限公司 | 抗感染的方法、组合物和装置 |
-
2014
- 2014-10-02 WO PCT/US2014/058911 patent/WO2015051183A1/en not_active Ceased
- 2014-10-02 CN CN201910299158.6A patent/CN110433291B/zh active Active
- 2014-10-02 CA CA2924748A patent/CA2924748C/en active Active
- 2014-10-02 MY MYPI2016000570A patent/MY179756A/en unknown
- 2014-10-02 KR KR1020167010978A patent/KR102320051B1/ko active Active
- 2014-10-02 CN CN201480054496.9A patent/CN105683184B/zh active Active
- 2014-10-02 MX MX2016004168A patent/MX363386B/es unknown
- 2014-10-02 AU AU2014329421A patent/AU2014329421B2/en active Active
- 2014-10-02 EP EP14851133.0A patent/EP3052487B1/en active Active
- 2014-10-02 US US14/505,379 patent/US9662394B2/en active Active
- 2014-10-02 SG SG11201602596UA patent/SG11201602596UA/en unknown
- 2014-10-02 JP JP2016546886A patent/JP6516759B2/ja active Active
-
2016
- 2016-03-31 PH PH12016500586A patent/PH12016500586B1/en unknown
- 2016-03-31 IL IL244850A patent/IL244850B/en active IP Right Grant
-
2017
- 2017-05-29 US US15/607,594 patent/US10342875B2/en active Active
-
2019
- 2019-03-07 JP JP2019041262A patent/JP6774518B2/ja active Active
- 2019-06-07 US US16/435,310 patent/US10864274B2/en active Active
-
2020
- 2020-07-09 JP JP2020118180A patent/JP2020169207A/ja active Pending
- 2020-12-11 US US17/119,780 patent/US12076404B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273205A (en) | Preparations and methods | |
| IL274355B (en) | Aza-pyridone compounds and their uses | |
| IL244850A0 (en) | Stabilized epinaconazole preparations, and their uses | |
| GB2520795B (en) | Compositions and methods | |
| GB2535911B (en) | Strigolactone formulations and uses thereof | |
| IL241225A0 (en) | Plant-based compositions and their uses | |
| GB201308072D0 (en) | Compositions and methods | |
| ZA201505966B (en) | Peptides and compositions | |
| GB201317286D0 (en) | Composition and Use | |
| EP2968474A4 (en) | SKIN COMPOSITIONS AND USES | |
| GB201323008D0 (en) | Compounds and uses thereof | |
| GB201321693D0 (en) | Composition and uses thereof | |
| SG11201509448WA (en) | Creamer compositions and uses thereof | |
| IL276126B (en) | Preparations containing l-4-chloroquinonerine and their uses | |
| GB201305813D0 (en) | Compositions and methods | |
| EP3007720A4 (en) | COMPOSITION COMPRISING THE GC MACROPHAGE ACTIVATION FACTOR AND USES THEREOF | |
| GB201322456D0 (en) | Radiotracer compositions and methods | |
| EP2964610A4 (en) | VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF | |
| GB201307233D0 (en) | Compounds and uses thereof | |
| SG11201505512UA (en) | Low-buffer nutritional compositions and uses thereof | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| GB201308242D0 (en) | Compositions and uses thereof | |
| GB201301022D0 (en) | Composition and uses thereof | |
| GB201322617D0 (en) | Methods and compositions | |
| GB201312393D0 (en) | Compositions and Methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |